Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04553471 · ClinicalTrials.gov registry record · NA
Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT04553471 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 70 participants.
The verdict
NCT04553471, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is a study evaluating the safety and efficacy of Lattice SBRT for patients with large tumors (≥ 4.5 cm) planning to undergo palliative radiotherapy.
Interventions
- RADIATION Stereotactic body radiotherapy
- PROCEDURE Research blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2023-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04553471
The ClinicalTrials.gov registry entry for NCT04553471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic body radiotherapy is the first listed.
NCT04553471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04553471 about?
NCT04553471 is a clinical study titled "Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers". This is a study evaluating the safety and efficacy of Lattice SBRT for patients with large tumors (≥ 4.5 cm) planning to undergo palliative radiotherapy.
What is the current status of trial NCT04553471?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2020-09-22. Estimated completion is 2023-05-04.
What interventions are being tested in trial NCT04553471?
The interventions under investigation include: Stereotactic body radiotherapy (RADIATION), Research blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT04553471?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.